Comment on Bloomberg website from a few days ago from GSK Spokesman in phone interview from London:
"Glaxo’s Rea said today that the drugmaker is producing Relenza at “full capacity.” Glaxo is “urgently assessing mechanisms to increase production of Relenza,” the company said in a statement."
Eventually BTA will bank the royalty cheque from this full capacity.
BTA story still has some legs.
Regards
Buffett
PS Suspect full capacity production of Relenza can top $33.2m for a quarter!
- Forums
- ASX - By Stock
- BTA
- bloomberg comment
bloomberg comment
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online